NCT05052398 - Proof of Principle Study Evaluating Gonyautoxins NEURO SERUM, on Chemotherapy-induced Peripheral Neuropathy | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

January 14, 2021

Primary Completion Date

July 11, 2024

Study Completion Date

July 14, 2025

Conditions

Chemotherapy-induced Peripheral Neuropathy

Interventions

DRUG

PSP NEURO SERUM

PSP NEURO SERUM is a topical product that contains a concentration of Paralytic Shellfish Toxins of 10 micrograms/mL of equivalent of Gonyautoxin 2/3. Each patient will apply 1 g of PSP NEURO SERUM in their hands, three times a day.

DRUG

Placebo PSP NEURO SERUM

Placebo PSP NEURO SERUM is the same topical product as PSP NEURO SERUM without the active ingredient. Each patient will apply 1 g of Placebo PSP NEURO SERUM in their hands, three times a day.

Trial Locations (9)

29050-400

RECRUITING

Oncoclínicas Vitória, Vitória

40.170-110

RECRUITING

Nucleo de Oncologia da Bahia, Salvador

30.360-680

RECRUITING

Oncoclinicas do Brasil Servicios Medicos SA, Belo Horizonte

38408-150

RECRUITING

Centro Oncológico do Triângulo S.A., Uberlândia

58030-080

RECRUITING

Oncoclínicas João Pessoa, João Pessoa

50070-460

RECRUITING

Multihemo, Recife

88015-020

RECRUITING

Oncoclínicas Florianópolis, Florianópolis

22250-905

RECRUITING

Oncoclinicas Rio de Janeiro SA, Rio de Janeiro

04538-132

RECRUITING

Centro de Paulista de Oncologia, São Paulo